You are viewing: North America Periodontal Disease Treatment Market analysis

The North America Periodontal Disease Treatment Market was valued at $773.8 Million in 2024 and projected to reach to $1113.2 Million by 2029, representing a compound annual growth rate of 6.2%. North America's periodontal disease treatment market is poised for sustained expansion driven by increasing disease prevalence, aging populations, and heightened oral health awareness.

North America Periodontal Disease Treatment Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Periodontal Disease Treatment Market Trends and Insights

  • North America's advanced healthcare infrastructure, high prevalence of periodontal disease, and strong adoption of innovative treatment technologies are driving this expansion.
  • The region benefits from established dental care systems, increasing patient awareness, and significant investment in oral health solutions. North America's market growth is supported by rising incidence of periodontal conditions linked to aging populations and lifestyle factors.
  • North America continues to lead in treatment innovation, with both surgical and non-surgical therapies gaining traction.
  • The forecast period through 2029 reflects North America's commitment to improving periodontal outcomes through advanced clinical practices and patient-centric care delivery..

Key Market Statistics

  • CAGR (2024-2029) 6.2% CAGR
  • Market Size, 2024 ~USD 773.8 Million
  • Forecast, 2029 ~USD 1113.2 Million
  • Geography North America

North America Periodontal Disease Treatment Market Overview

Market Valuation & Growth :

North America's periodontal disease treatment market is valued at $773.8 million in 2024, with a projected CAGR of 6.2% through 2029, reaching $1,113.2 million. This growth outpaces the global CAGR of 5.9%, positioning North America as a high-growth region.

Advanced Healthcare Infrastructure :

The region benefits from world-class dental care systems, state-of-the-art treatment facilities, and widespread access to periodontal specialists. North America's established healthcare framework supports rapid adoption of innovative treatment modalities and technologies.

High Disease Prevalence :

Periodontal disease affects a significant portion of the North American population, with increasing awareness driving demand for professional treatment. The prevalence of gingivitis and periodontitis creates sustained market demand across all demographic segments.

Technology Adoption Leadership :

North America leads in adopting cutting-edge periodontal treatments including laser therapy, regenerative procedures, and digital diagnostics. Strong investment in dental innovation and early technology adoption accelerates market expansion in the region.

North America Periodontal Disease Treatment Market Dynamics

  • The region's robust reimbursement landscape and established dental insurance coverage support patient access to advanced treatments, while dental professionals continue investing in state-of-the-art equipment and techniques. The forecast period through 2029 will witness accelerated growth as minimally invasive procedures gain traction and regenerative periodontal therapies become mainstream.
  • Rising healthcare expenditure, coupled with growing cosmetic dentistry demand, will further propel market growth.
  • North America's leadership in clinical research and treatment innovation positions it as a key driver of global periodontal market evolution..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • North America's periodontal disease treatment market will grow from $773.8M (2024) to $1,113.2M (2029) at a 6.2% CAGR.
      • North America leads in adoption of advanced periodontal therapies, including laser-assisted and regenerative treatment modalities.
      • Aging demographics and increased periodontal disease prevalence are primary growth drivers across North America.
      • North America's mature healthcare reimbursement systems and strong dental insurance coverage support sustained market expansion.

      Periodontal Disease Treatment Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment AGGRESSIVE PERIODONTITIS (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 5.9% from 2024 to 2029
      Largest Segment NON-SURGICAL TREATMENT (Treatment)
      Market Size Base Year (Billions) ~USD 2.57 (2024)
      Revenue Forecast (Billions) ~USD 3.43 (2029)
      Segments Covered Product, Disease, Type, Treatment

      North America Periodontal Disease Treatment Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Consumables
      • Equipment
      • Medication

      By Disease

      • Aggressive Periodontitis
      • Chronic Periodontitis
      • Gingivitis
      • Other Diseases

      By Type

      • Acute Gingivitis
      • Chronic Gingivitis
      • Medication Therapy
      • Recurrent Gingivitis
      • Root Planing
      • Scaling

      By Treatment

      • Bone Grafting
      • Flap Surgery/Pocket Reduction Therapy
      • Guided Tissue Regeneration
      • Non-Surgical Treatment
      • Other Treatments
      • Soft Tissue Graft

      Target Audience

      • Dental Device Manufacturers : Manufacturers need North America-specific market data to optimize product development, pricing, and distribution strategies. Understanding regional treatment preferences and technology adoption rates is critical for competitive positioning and revenue growth.
      • Periodontal Treatment Providers : Dental practices and periodontal specialists require market insights to identify growth opportunities, benchmark performance, and plan service expansion. Regional data helps optimize treatment offerings and patient acquisition strategies.
      • Healthcare Investors & PE Firms : Investment professionals need comprehensive market sizing and growth forecasts to evaluate acquisition targets and portfolio companies in North America's dental sector. Regional CAGR and valuation data inform investment decisions and exit strategies.
      • Pharmaceutical & Biotech Companies : Companies developing periodontal therapeutics and regenerative treatments need North America market data to assess commercial potential and guide R&D investments. Regional prevalence and treatment adoption rates inform go-to-market strategies.
      • Healthcare Consultants & Analysts : Consultants advising healthcare organizations require detailed North American market intelligence to support strategic planning, competitive analysis, and market opportunity assessments for clients in the dental and periodontal sectors.

      Key Companies in the North America Periodontal Disease Treatment Market

      CompanyHQOwnershipStrongest segments
      DENTSPLY SIRONAUnited StatesPublic CompanyConnected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions,
      ENVISTA HOLDINGS CORPORATIONUnited StatesPublic CompanySpecialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization,
      HENRY SCHEIN, INC.United StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      BIOLASE, INC.United StatesPublic CompanyWaterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces,
      NAKANISHI INC.JapanPublic CompanyDental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products,
      A-DEC INC.SwitzerlandPublic CompanyFlexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting,

      DENTSPLY SIRONA

      DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.

      ENVISTA HOLDINGS CORPORATION

      ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.

      HENRY SCHEIN, INC.

      HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.

      BIOLASE, INC.

      BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.

      NAKANISHI INC.

      NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.

      A-DEC INC.

      A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 1239.4 Million · 4.7% wtd CAGR ·
      Asia Pacific
      ~USD 851.6 Million · 6.9% wtd CAGR ·
      Middle East & Africa
      ~USD 126 Million · 7.8% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 412.07 Million
      CanadaUSD 106.73 Million
      MexicoUSD 23.45 Million

      Country market size visualization

      US
      USD 412.07 Million
      Canada
      USD 106.73 Million
      Mexico
      USD 23.45 Million

      Reasons to Buy this Report

      • Regional Market Segmentation : Gain detailed insights into North America's periodontal market dynamics, including country-level breakdowns for the US, Canada, and Mexico. Understand regional variations in treatment adoption, pricing strategies, and competitive landscapes specific to North American markets.
      • Growth Trajectory Analysis : Access comprehensive forecasting data showing 6.2% CAGR through 2029, with detailed year-by-year projections. Identify growth inflection points and market expansion opportunities unique to North America's healthcare ecosystem.
      • Competitive Intelligence : Benchmark your position against regional competitors and understand market consolidation trends. Identify leading treatment providers, emerging players, and partnership opportunities within North America's periodontal sector.
      • Technology & Innovation Trends : Discover which advanced periodontal technologies are gaining traction in North America, including laser therapy, regenerative procedures, and digital diagnostics. Stay ahead of treatment innovation adoption curves specific to the region.
      • Strategic Market Entry : Develop data-driven market entry strategies with insights into reimbursement policies, regulatory requirements, and patient demographics across North American markets. Identify high-opportunity segments and geographic hotspots for expansion.

      Frequently asked questions

      What is the current size of the North America periodontal disease treatment market?

      The North America periodontal disease treatment market was valued at $773.8 million in 2024 and is expected to reach $1,113.2 million by 2029.

      What is the projected growth rate for North America's periodontal treatment market?

      North America's periodontal disease treatment market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2029.

      What factors are driving growth in North America's periodontal disease treatment market?

      Key drivers include aging populations, rising periodontal disease prevalence, advanced treatment technology adoption, strong healthcare infrastructure, and comprehensive dental insurance coverage across North America.

      Which treatment modalities are most prevalent in North America?

      North America shows strong adoption of both surgical and non-surgical periodontal treatments, including scaling and root planing, laser-assisted therapies, and regenerative procedures.

      How does North America's market compare to global trends?

      North America's 6.2% CAGR slightly exceeds the global average of 5.9%, reflecting the region's advanced healthcare systems and higher treatment adoption rates.

      RESEARCH METHODOLOGY

      Get the Full Periodontal Disease Treatment Market Report

      Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status